跳至主要内容
临床试验/TCTR20190509004
TCTR20190509004已完成未知

Efficacy of Submucosal Tramadol and Lidocaine on Success Rate of Inferior Alveolar Nerve Block in Mandibular Molars with Symptomatic Irreversible Pulpitis: A Randomized, Controlled, Double-Blind Clinical Study

none0 个研究点目标入组 105 人开始时间: 2019年5月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
105

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • 1. A single mandibular molar tooth responding to cold test for a long time and diagnosed with symptomatic irreversible pulpitis
  • 2. Patients with preoperative pain scores ranging from moderate to severe (55â€170 mm) on a Heft-Parker visual analog scale (HP VAS, 0â€170 mm)
  • 3. The absence of periapical radiolucency on periapical radiography (except enlarged periodontal ligaments not larger than 0.75-1 mm)
  • 4. Have the ability to understand the informed consent form and pain record scales to be used within the study

排除标准

  • 1. Receiving analgesic or anti-inflammatory drugs within 24 hours prior to treatment
  • 2. Allergy or susceptibility to any opioid or nonopioid analgesia, including lidocaine, tramadol or NSAIDs
  • 3. Pregnant or nursing, those with any bleeding problem or those using anticoagulant medication
  • 4. Patients have not lip numbness following initial IANB injection
  • 4. In addition to hypersensitive teeth to percussion and palpation; teeth have calcified root canals, periodontal diseases, root resorption, open apex, necrotic pulp and have already been undergone root canal treatment were excluded from the study.

研究者

发起方
none

相似试验

Efficacy of Submucosal Tramadol and Lidocaine on... | 临床试验